Vasculitis

Yair Molad

doi:10.1007/978-3-319-59963-2_12

Vasculitis

Yair Molad^*

^*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Vasculitis is a heterogeneous group of disorders characterized by inflammation of the wall of blood vessels of various sizes, including veins, arteries, and capillaries. Comorbidities may occur as an intrinsic component of systemic vasculitis or as adverse effects of treatment. This chapter describes the various comorbidities associated with vasculitis, with emphasis on atherosclerotic cardiovascular disease, treatment-associated infections, thrombosis, and malignancy. Careful and meticulous assessment of comorbidities is mandatory at the time of diagnosis of the various vasculitides as well as during the active phase and at remission.

Original language	English
Title of host publication	Comorbidity in Rheumatic Diseases
Publisher	Springer International Publishing
Pages	245-264
Number of pages	20
ISBN (Electronic)	9783319599632
ISBN (Print)	9783319599625
DOIs	https://doi.org/10.1007/978-3-319-59963-2_12
State	Published - 24 Aug 2017
Externally published	Yes

Keywords

Behçet's disease
Cardiovascular disease
Charlson comorbidity index (CCI)
Comorbidity in vasculitis
Infections in vasculitis
Malignancy and vasculitis
Metabolic syndrome in vasculitis
Takayasu arteritis
Thrombosis in vasculitis
Vasculitis

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-319-59963-2_12

Cite this

@inbook{95e831c1400a4aec822eafe04233d770,

title = "Vasculitis",

abstract = "Vasculitis is a heterogeneous group of disorders characterized by inflammation of the wall of blood vessels of various sizes, including veins, arteries, and capillaries. Comorbidities may occur as an intrinsic component of systemic vasculitis or as adverse effects of treatment. This chapter describes the various comorbidities associated with vasculitis, with emphasis on atherosclerotic cardiovascular disease, treatment-associated infections, thrombosis, and malignancy. Careful and meticulous assessment of comorbidities is mandatory at the time of diagnosis of the various vasculitides as well as during the active phase and at remission.",

keywords = "Beh{\c c}et's disease, Cardiovascular disease, Charlson comorbidity index (CCI), Comorbidity in vasculitis, Infections in vasculitis, Malignancy and vasculitis, Metabolic syndrome in vasculitis, Takayasu arteritis, Thrombosis in vasculitis, Vasculitis",

author = "Yair Molad",

note = "Publisher Copyright: {\textcopyright} Springer International Publishing AG 2017.",

year = "2017",

month = aug,

day = "24",

doi = "10.1007/978-3-319-59963-2_12",

language = "אנגלית",

isbn = "9783319599625",

pages = "245--264",

booktitle = "Comorbidity in Rheumatic Diseases",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Vasculitis

AU - Molad, Yair

N1 - Publisher Copyright: © Springer International Publishing AG 2017.

PY - 2017/8/24

Y1 - 2017/8/24

N2 - Vasculitis is a heterogeneous group of disorders characterized by inflammation of the wall of blood vessels of various sizes, including veins, arteries, and capillaries. Comorbidities may occur as an intrinsic component of systemic vasculitis or as adverse effects of treatment. This chapter describes the various comorbidities associated with vasculitis, with emphasis on atherosclerotic cardiovascular disease, treatment-associated infections, thrombosis, and malignancy. Careful and meticulous assessment of comorbidities is mandatory at the time of diagnosis of the various vasculitides as well as during the active phase and at remission.

AB - Vasculitis is a heterogeneous group of disorders characterized by inflammation of the wall of blood vessels of various sizes, including veins, arteries, and capillaries. Comorbidities may occur as an intrinsic component of systemic vasculitis or as adverse effects of treatment. This chapter describes the various comorbidities associated with vasculitis, with emphasis on atherosclerotic cardiovascular disease, treatment-associated infections, thrombosis, and malignancy. Careful and meticulous assessment of comorbidities is mandatory at the time of diagnosis of the various vasculitides as well as during the active phase and at remission.

KW - Behçet's disease

KW - Cardiovascular disease

KW - Charlson comorbidity index (CCI)

KW - Comorbidity in vasculitis

KW - Infections in vasculitis

KW - Malignancy and vasculitis

KW - Metabolic syndrome in vasculitis

KW - Takayasu arteritis

KW - Thrombosis in vasculitis

KW - Vasculitis

UR - http://www.scopus.com/inward/record.url?scp=85055366625&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-59963-2_12

DO - 10.1007/978-3-319-59963-2_12

M3 - ???researchoutput.researchoutputtypes.contributiontobookanthology.chapter???

AN - SCOPUS:85055366625

SN - 9783319599625

SP - 245

EP - 264

BT - Comorbidity in Rheumatic Diseases

PB - Springer International Publishing

ER -

Vasculitis

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this